维普中文期刊产品整合服务
57篇 您的检索式:作者名="Peters DD"
    题名 作者 年代 出处 被引量
1重组脊髓灰质炎病毒用于治疗复发胶质母细胞瘤(英文)显示文摘Background The prognosis of patients with recurrent World Health Organization(WHO)grade IV malignant glioma is dismal,and there is currently no effective therapy.We conducted a dose-finding and toxicity study in this population of patients,evaluating convection-enhanced,intratumoral delivery of the recombinant nonpathogenic polio-rhinovirus chimera(PVSRIPO).PVSRIPO recognizes the poliovirus receptor CD155,which is widely expressed in neoplastic cells of solid tumors and in major components of the tumor microenvironment.Methods We enrolled consecutive adult patients who had recurrent supratentorial WHO grade IV malignant glioma,confirmed on histopathological testing,with measurable disease(contrast-enhancing tumor of≥1 cm and≤5.5 cm in the greatest dimension).The study evaluated seven doses,ranging between 107 and 1010 50%tissue-culture infectious doses(TCID50),first in a dose-escalation phase and then in a dose-expansion phase.Results From May 2012 through May 2017,a total of 61 patients were enrolled and received a dose of PVSRIPO.Dose level-1(5.0×107TCID50)was identified as the phase 2 dose.One dose-limiting toxic effect was observed;a patient in whom dose level 5(1010TCID50)was administered had a grade 4 intracranial hemorrhage immediately after the catheter was removed.To mitigate locoregional inflammation of the infused tumor with prolonged glucocorticoid use,dose level 5 was deescalated to reach the phase 2 dose.In the dose-expansion phase,19%of the patients had a PVSRIPO-related adverse event of grade 3 or higher.Overall survival among the patients who received PVSRIPO reached a plateau of 21%(95%confidence interval,11 to 33)at 24 months that was sustained at 36 months.Conclusions Intratumoral infusion of PVSRIPO in patients with recurrent WHO grade IV malignant glioma confirmed the absence of neurovirulent potential.The survival rate among patients who receivedPVSRIPO immunotherapy was higher at 24 and 36 months than the rate among historical controls.Desjardins A Gromeier M Herndon JE 2nd Beaubier N Bolognesi DP Friedman AH Friedman HS McSherry F Muscat AM Nair S Peters KB Randazzo D Sampson JH Vlahovic G Harrison WT McLendon RE Ashley D Bigner DD 2018中华神经外科疾病研究杂志2018,17,4:2
2Incidence and configuration of canal systemsin the mesiobuccal root of maxillary first and second molars显示文摘Kulid J Peters DD 1990JEndodon1990,16,:1
3Incidence and configuration of canal systems in the mesiobuccal root of maxillary first and second molars 显示文摘Kulid JC Peters DD 1990J Endod1990,16,7:1
4Incidence and configuration of canal systems in the mesiobuccal root of maxillary first and second molars显示文摘Kulild JC Peters DD 1990J Endod1990,16,7:1
5Incidence and configuration of canal system in the mesiobuccal root of maxillary first and second molars 显示文摘Kulid JC Peters DD 1990J Endod1990,16,7:1
6A comparison of the area of the canal space occupied by gutta-percha following four gutta- percha obturation techniques using Procosol sealer 显示文摘Eguchi DS Peters DD Hollinger JO 1985J Endod1985,11,4:1
7Incidence and coni'iguratim of canal systems in the mesiobuccal root of maxillmw first and seeon molars显示文摘Kulild JC Peters DD 1990l Endod1990,16,7:1
8Microcomputed tomography:An advanced system for detailed endodontic research显示文摘Nielsen RB Alyassin AM Peters DD 1995J Endod1995,21,11:1
9Incidence and configuration of canal systems in the mesiobuccal root of maxillary first and second molars显示文摘Kulild JC Peters DD 2000J Endod2000,16,2:1
10Incidence and configuration of canal sys- tems in the mesiobuccal root of maxillary first and second molars 显示文摘Kulild JC Peters DD 1990JEndod1990,16,7:1
11Negative feedback control of HIF-l through REDDl-regulated ROS suppresses tumor?igenesis显示文摘Peter H Crawford AR Vadysirisack DD 2010Proc Natl Acad Sci USA2010,107,10:1
12Evidence for diminished levels of epithelial psoriasin and calprotein in chronic rhinosinusitis显示文摘Tieu DD Peters AT Carter RT 2010J Allergy Clin Immunol2010,125,3:1
13Microcomputedtomography : An advanced system for detailed endodontic re-search显示文摘Nielsen RB Alyassin AM Peters DD 1995J Endod1995,21,11:1
14Incidence and configuration of canal systems in the mesiobuccal root of maxillary first and second molars显示文摘Kulild JC Peters DD 1990J Endod1990,16,7:1
15The Perioperative Management of Antithrombotic Therapy-American College of Chest Physicians Evidence-Based Clinical Practice Guidelines ( 8th Edition ) 显示文摘James DD Peter BB 2008CHEST2008,133,6:1
16Incidence and configuration of canal systems in the mesiobuccal root of maxillary first and second molars显示文摘Kulid J Peters DD 1990J Endodon1990,16,:1
17Comparison of gutta - percha filling techniques,corspaction(mechnical) ,vertical(warm) , and lateral condensation techniques, Part 1 显示文摘Wong M Peters DD Lorton L 1981J Endod1981,7,:1
18Incidence and configuration of canal systems in the mesiobuccal root of maxillary first and second molars 显示文摘Kulild JC Peters DD 1990J Endod1990,16,7:1
19Comparison of gutta-percha filling techniques, compaction (meehnieal), vertical (warm), and lateral condensation techniques, Part 1显示文摘Wong M Peters DD Lorton L 1981J Endod1981,7,:1
20Prospective navigator correction of image position for coronary MR angiography显示文摘Peter DD Michael VM Vaibhav CK 1997Radiology1997,203,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费